Hem › Bröstcancer › Kalifornien
Kliniska studier för Bröstcancer i Kalifornien
179 studier för Bröstcancer söker deltagare vid platser i Kalifornien.
Städer i Kalifornien
- Los Angeles73 studier
- Baldwin Park44 studier
- San Francisco43 studier
- San Diego41 studier
- Santa Monica28 studier
- Mountain View26 studier
- Irvine23 studier
- Sacramento20 studier
- Newport Beach16 studier
- Orange14 studier
- Santa Rosa11 studier
- Vallejo10 studier
- Torrance9 studier
- Burbank9 studier
- Fullerton9 studier
- Concord9 studier
- Long Beach9 studier
- Santa Clara7 studier
- Richmond7 studier
- Roseville7 studier
- Oakland7 studier
- Stockton7 studier
- Westminster7 studier
- Huntington Beach6 studier
- Fremont6 studier
- Pleasanton6 studier
- Redwood City6 studier
- Fresno6 studier
- San Jose6 studier
- Indio6 studier
- Santa Barbara6 studier
- Anaheim5 studier
- Modesto5 studier
- Santa Maria5 studier
- Bakersfield4 studier
- Glendale4 studier
- Pasadena4 studier
- Riverside4 studier
- San Leandro4 studier
- Vacaville4 studier
- San Marcos4 studier
- Antioch4 studier
- Daly City4 studier
- Whittier4 studier
- Alhambra4 studier
- Arden-Arcade4 studier
- Elk Grove4 studier
- San Bernardino4 studier
- Bellflower3 studier
- Ontario3 studier
- Santa Clarita3 studier
- Salinas3 studier
- Upland3 studier
- Berkeley3 studier
- Sunnyvale3 studier
- San Mateo3 studier
- Norwalk3 studier
Officiell studietext (engelska)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
RekryterarFriska volontärer välkomna
Ålder 45 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06995898Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
- Research Site, Los Angeles
- Research Site, San Francisco
RekryterarFas 1/2
Ålder 18 till 130 · Alla kön · Uppdaterad 5 okt. 2026 · NCT05417594Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Beverly Hills Cancer Center, Beverly Hills
- City of Hope National Medical Center, Duarte
- Cedars-Sinai Medical Center, Los Angeles
- och 5 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT06982521A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT06840886The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
RekryterarFas 1/2
Ålder 12 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT04585750A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06760819Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Onco Inst of Hope and Innovation, Cerritos
- City of Hope National Medical, Duarte
- Providence Medical Foundation, Fullerton
- och 7 fler
RekryterarFas 3
Ålder 18 till 100 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05827081Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- och 10 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- och 20 fler
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Oncology Institute, Long Beach
- Cancer & Blood Research Center, Los Alamitos
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07102381A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06172478A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
- Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
- Stanford Medicine Cancer Center, Stanford
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT07701941Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
- City of Hope Medical Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- City of Hope at Long Beach Elm, Long Beach
- och 1 fler
RekryterarFas 2
Ålder 70 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT04305834A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Beverly Hills Cancer Center, Beverly Hills
- MemorialCare Orange Coast Medical Center, Fountain Valley
- City of Hope at Orange County Lennar Foundation Cancer Center, Irvine
- och 3 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06369285Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- City of Hope Comprehensive Cancer Center, Duarte
- University of California Los Angeles, Los Angeles
- University of California San Diego Moores Cancer Center, San Diego
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06625775Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- The Oncology Institute of Hope and Innovation, Cerritos
- Ellison Medical Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
- och 3 fler
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 30 sep. 2026 · NCT06324357Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- California Protons Cancer Therapy Center, San Diego
RekryterarFas 2
Ålder 50 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT01766297A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Duarte
- Research Site, Los Angeles
- Research Site, Newport Beach
- och 1 fler
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 29 sep. 2026 · NCT05877599Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
- California Protons Cancer Therapy Center, San Diego
RekryterarFas 3
Ålder 19 och äldre · Kvinnor · Uppdaterad 29 sep. 2026 · NCT05856773IKS014 in Advanced Solid Tumors That Express HER2
- Hoag Memorial Hospital Presbyterian, Newport Beach
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT05872295A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07060807A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Providence Medical Foundation-Oncology ( Site 0020), Fullerton
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06312176A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Fountain Valley
- Research Site, Glendale
- Research Site, Sacramento
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06103864The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Providence Medical Foundation, Eureka
- Providence Medical Foundation, Santa Rosa
RekryterarFas 3
Ålder 60 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06377852ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- City of Hope, Duarte
- UC San Diego Moores Cancer Center, La Jolla
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07007559A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Roy and Patricia Disney Family Cancer Center ( Site 0055), Burbank
- Community Cancer Institute ( Site 0100), Clovis
- Providence Medical Foundation ( Site 0080), Fullerton
- och 4 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06966700A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
- Los Angeles Cancer Network, Los Angeles
- Community Clinical Trials, Orange
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 25 sep. 2026 · NCT07054190A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07229313Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Marin Cancer Care, Greenbrae
- Loma Linda University, Loma Linda
- Cancer and Blood Research Center, Los Alamitos
- och 3 fler
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT07214532A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills
RekryterarFas 1
Ålder 18 till 80 · Kvinnor · Uppdaterad 23 sep. 2026 · NCT07401381Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Beverly Hills
- Clinical Trial Site, La Jolla
- Clinical Trial Site, Los Alamitos
- och 8 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT07085767A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07114601A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213791A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Community Cancer Institute, Clovis
- City of Hope, Duarte
- Epic Care - Emeryville, Emeryville
- och 19 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07174336A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- City of Hope, Duarte
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- USC/Norris Comprehensive Cancer Center, Los Angeles
- och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Kvinnor · Uppdaterad 22 sep. 2026 · NCT07287098Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- University of California Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California Davis, Sacramento
- och 2 fler
RekryterarFriska volontärer välkomna
Ålder 30 till 74 · Kvinnor · Uppdaterad 21 sep. 2026 · NCT02620852A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Disney Family Cancer Center, Burbank
- City of Hope, Corona
- City of Hope Comprehensive Cancer Center, Duarte
- och 2 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 21 sep. 2026 · NCT05894239Pulsed Electric Field Ablation for Metastatic Breast Cancer
- University of California San Francisco, San Francisco
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 18 sep. 2026 · NCT07487844A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Beverly Hills Cancer Center, Beverly Hills
- Hoag Memorial Hospital Presbyterian, Newport Beach
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06827236ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- University Of California - San Diego Moores Cancer Center, La Jolla
- Cancer and Blood Specialty Clinic (CBSC), Los Alamitos
- Cedar Sinai - Samuel Oschin Cancer Center, Los Angeles
- och 4 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT07173751Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.